| 000 | 01717 a2200421 4500 | ||
|---|---|---|---|
| 005 | 20250516012035.0 | ||
| 264 | 0 | _c20110314 | |
| 008 | 201103s 0 0 eng d | ||
| 022 | _a1532-2238 | ||
| 024 | 7 |
_a10.1016/j.ghir.2010.10.002 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aVarewijck, A J | |
| 245 | 0 | 0 |
_aInsulin glargine is more potent in activating the human IGF-I receptor than human insulin and insulin detemir. _h[electronic resource] |
| 260 |
_bGrowth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society _cDec 2010 |
||
| 300 |
_a427-31 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Evaluation Study; Journal Article | ||
| 650 | 0 | 4 |
_aAntigens, CD _xmetabolism |
| 650 | 0 | 4 | _aCells, Cultured |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 |
_aEnzyme Activation _xdrug effects |
| 650 | 0 | 4 |
_aEnzyme Assays _xmethods |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHypoglycemic Agents _xpharmacology |
| 650 | 0 | 4 |
_aInsulin _xanalogs & derivatives |
| 650 | 0 | 4 | _aInsulin Detemir |
| 650 | 0 | 4 | _aInsulin Glargine |
| 650 | 0 | 4 | _aInsulin, Long-Acting |
| 650 | 0 | 4 | _aOsmolar Concentration |
| 650 | 0 | 4 |
_aReceptor, IGF Type 1 _xagonists |
| 650 | 0 | 4 |
_aReceptor, Insulin _xagonists |
| 700 | 1 | _aGoudzwaard, J A | |
| 700 | 1 | _aBrugts, M P | |
| 700 | 1 | _aLamberts, S W J | |
| 700 | 1 | _aHofland, L J | |
| 700 | 1 | _aJanssen, J A M J L | |
| 773 | 0 |
_tGrowth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society _gvol. 20 _gno. 6 _gp. 427-31 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.ghir.2010.10.002 _zAvailable from publisher's website |
| 999 |
_c20354745 _d20354745 |
||